Literature DB >> 19800575

A lymphotoxin-driven pathway to hepatocellular carcinoma.

Johannes Haybaeck1, Nicolas Zeller, Monika Julia Wolf, Achim Weber, Ulrich Wagner, Michael Odo Kurrer, Juliane Bremer, Giandomenica Iezzi, Rolf Graf, Pierre-Alain Clavien, Robert Thimme, Hubert Blum, Sergei A Nedospasov, Kurt Zatloukal, Muhammad Ramzan, Sandra Ciesek, Thomas Pietschmann, Patrice N Marche, Michael Karin, Manfred Kopf, Jeffrey L Browning, Adriano Aguzzi, Mathias Heikenwalder.   

Abstract

Hepatitis B and C viruses (HBV and HCV) cause chronic hepatitis and hepatocellular carcinoma (HCC) by poorly understood mechanisms. We show that cytokines lymphotoxin (LT) alpha and beta and their receptor (LTbetaR) are upregulated in HBV- or HCV-induced hepatitis and HCC. Liver-specific LTalphabeta expression in mice induces liver inflammation and HCC, causally linking hepatic LT overexpression to hepatitis and HCC. Development of HCC, composed in part of A6(+) oval cells, depends on lymphocytes and IKappa B kinase beta expressed by hepatocytes but is independent of TNFR1. In vivo LTbetaR stimulation implicates hepatocytes as the major LT-responsive liver cells, and LTbetaR inhibition in LTalphabeta-transgenic mice with hepatitis suppresses HCC formation. Thus, sustained LT signaling represents a pathway involved in hepatitis-induced HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800575      PMCID: PMC4422166          DOI: 10.1016/j.ccr.2009.08.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  45 in total

1.  Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway.

Authors:  Jennifer L Gommerman; Fabienne Mackay; Elina Donskoy; Werner Meier; Pauline Martin; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.

Authors:  J L Browning; I D Sizing; P Lawton; P R Bourdon; P D Rennert; G R Majeau; C M Ambrose; C Hession; K Miatkowski; D A Griffiths; A Ngam-ek; W Meier; C D Benjamin; P S Hochman
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

3.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Authors:  Y Cao; G Bonizzi; T N Seagroves; F R Greten; R Johnson; E V Schmidt; M Karin
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

5.  Chronic lymphocytic inflammation specifies the organ tropism of prions.

Authors:  Mathias Heikenwalder; Nicolas Zeller; Harald Seeger; Marco Prinz; Peter-Christian Klöhn; Petra Schwarz; Nancy H Ruddle; Charles Weissmann; Adriano Aguzzi
Journal:  Science       Date:  2005-01-20       Impact factor: 47.728

6.  Autocrine activity of interleukin 6 secreted by hepatocarcinoma cell lines.

Authors:  G Baffet; T A Braciak; R G Fletcher; J Gauldie; G H Fey; W Northemann
Journal:  Mol Biol Med       Date:  1991-02

Review 7.  Newer markers for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Anna S F Lok
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

Review 9.  The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Authors:  M Zeremski; L M Petrovic; A H Talal
Journal:  J Viral Hepat       Date:  2007-10       Impact factor: 3.728

10.  T cell-derived lymphotoxin regulates liver regeneration.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Peter A Christiansen; Mehtab A Khan; Matthew J Ruddy; Byron Burnette; Salvatore Papa; Guido Franzoso; Sergei A Nedospasov; Yang-Xin Fu; Robert A Anders
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

View more
  159 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  An additional long-term mechanism of NF-κB regulation after cytokine treatment in a human hepatoma cell line.

Authors:  Patricia Kohlhof
Journal:  Virchows Arch       Date:  2010-09-23       Impact factor: 4.064

Review 3.  Dual roles for immunity in gastrointestinal cancers.

Authors:  Cristina Ferrone; Glenn Dranoff
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 4.  NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors:  Guobin He; Michael Karin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

5.  Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

Authors:  Marie-Luise Berres; Rory R Koenen; Anna Rueland; Mirko Moreno Zaldivar; Daniel Heinrichs; Hacer Sahin; Petra Schmitz; Konrad L Streetz; Thomas Berg; Nikolaus Gassler; Ralf Weiskirchen; Amanda Proudfoot; Christian Weber; Christian Trautwein; Hermann E Wasmuth
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

Review 6.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.

Authors:  Li-Rung Huang; Dirk Wohlleber; Florian Reisinger; Craig N Jenne; Ru-Lin Cheng; Zeinab Abdullah; Frank A Schildberg; Margarete Odenthal; Hans-Peter Dienes; Nico van Rooijen; Edgar Schmitt; Natalio Garbi; Michael Croft; Christian Kurts; Paul Kubes; Ulrike Protzer; Mathias Heikenwalder; Percy A Knolle
Journal:  Nat Immunol       Date:  2013-04-14       Impact factor: 25.606

Review 8.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 9.  Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.

Authors:  Ekaterina P Koroleva; Yang-Xin Fu; Alexei V Tumanov
Journal:  Cytokine       Date:  2016-09-09       Impact factor: 3.861

10.  Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.

Authors:  Emily Corse; Rachel A Gottschalk; Joon Seok Park; Manuel A Sepulveda; P'ng Loke; Timothy J Sullivan; Linda K Johnson; James P Allison
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.